Life Sciences M&A Keeps Rolling After Inversion Clampdown
Life sciences M&A remains strong through the start of the fourth quarter, priming the sector for a strong finish to 2014 even after the U.S. government clamped down on tax-motivated deals...To view the full article, register now.
Already a subscriber? Click here to view full article